Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
Xponential Fitness $120 million IPO and $200 million convertible offering
We advised Xponential Fitness on its concurrent IPO, NYSE listing and convertible preferred offering
Royalty Pharma $1.3 billion senior notes offering
We advised Royalty Pharma on its SEC-registered investment-grade notes offering, including $600 million in social bonds
Constellation Brands $1 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
Couchbase $230.2 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Natera $584.8 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
Ryan Specialty Group $1.538 billion IPO
We advised the joint lead book-running managers on the IPO and NYSE listing
Zenvia $150 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Grupo de Moda Soma $883.4 million stock offering
We advised the underwriters in connection with the equity offering
Kaltura $150 million IPO
We advised the underwriters on the IPO and Nasdaq listing